{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:43:17Z","timestamp":1770752597531,"version":"3.50.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010621","name":"Uniwersytet Medyczny w Lublinie","doi-asserted-by":"publisher","award":["PBsd 120\/2021-2022"],"award-info":[{"award-number":["PBsd 120\/2021-2022"]}],"id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010621","name":"Uniwersytet Medyczny w Lublinie","doi-asserted-by":"publisher","award":["DS 358\/2020-2022"],"award-info":[{"award-number":["DS 358\/2020-2022"]}],"id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Epicardial adipose tissue (EAT) is a metabolically active visceral fat depot contributing to coronary atherosclerosis, yet the molecular mechanisms underlying EAT-related coronary artery disease (CAD) in type 2 diabetes mellitus (T2DM) remain unclear. Previously, we identified novel circulating miRNAs targeting fatty acid metabolism in T2DM-CAD. This study aimed to investigate whether EAT may explain the association between dysregulated hsa-miR-4505, hsa-miR-4743-5p, hsa-miR-4750-3p and CAD in T2DM patients and whether it can detect diabetic atherosclerosis alone or in a multi-modal combination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Seventy-six patients with T2DM and\/or CAD along with eighteen healthy controls were enrolled in the study. All participants underwent transthoracic echocardiography to assess EAT thickness on the free wall of the right ventricle at end-systole and bioelectrical impedance analysis for body composition determination. Spearman\u2019s rank correlation and multivariate linear regression accounting for relevant clinical confounders were used to explore the associations between EAT and miRNAs. To further investigate whether EAT acts as an intermediary between miRNA and CAD in T2DM, causal mediation analysis was employed. The receiver operating characteristics curves were generated to evaluate the diagnostic performance of the combined models built using multivariate logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The median EAT thickness was significantly higher in T2DM-CAD patients compared to T2DM subjects and controls (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001). The bivariate analysis showed a positive correlation between triglyceride concentration and EAT thickness, and a negative one with hsa-miR-4750-3p expression. After multivariable adjustment, hsa-miR-4750-3p (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      = \u2212 0.445,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003) emerged as a standalone predictor of EAT thickness. Logistic regression analysis identified enlarged EAT, up-regulated hsa-miR-4505, hsa-miR-4743-5p and down-regulated hsa-miR-4750-3p to be independently associated with higher CAD risk in T2DM. Adding miRNAs to EAT improved CAD detection in T2DM (AUC\u2009=\u20090.988), outperforming both EAT (AUC\u2009=\u20090.869), clinical factors (AUC\u2009=\u20090.829), and their combination (AUC\u2009=\u20090.901). The mediation analysis revealed that EAT accounted for 48.79% of the total effect of hsa-miR-4750-3p on CAD in T2DM.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings suggest that the proposed miRNA-EAT regulatory axis may be involved in the pathogenesis of diabetic atherosclerosis, with EAT appearing to partially mediate the relationship between hsa-miR-4750-3p and CAD. The integrated approach linking EAT and miRNAs holds potential for CAD risk stratification in T2DM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-025-03055-2","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T12:52:19Z","timestamp":1768481539000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epicardial adipose tissue mediates the association between circulating hsa-miR-4750-3p and coronary artery disease in patients with type 2 diabetes mellitus"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3744-9058","authenticated-orcid":false,"given":"Joanna","family":"Szyde\u0142ko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Zapolski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Lenart-Lipi\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Czop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicja","family":"Petniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janusz","family":"Kocki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Matyjaszek-Matuszek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,15]]},"reference":[{"key":"3055_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.","journal-title":"Diabetes Res Clin Pract"},{"key":"3055_CR2","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","volume":"148","author":"SS Virani","year":"2023","unstructured":"Virani SS, Newby LK, Arnold SV, Bittner V, Brewer LC, Demeter SH, et al. 2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American heart Association\/American college of cardiology joint committee on clinical practice guidelines. Circulation. 2023;148:e9-119.","journal-title":"Circulation"},{"key":"3055_CR3","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","volume":"44","author":"N Marx","year":"2023","unstructured":"Marx N, Federici M, Sch\u00fctt K, M\u00fcller-Wieland D, Ajjan RA, Antunes MJ, et al. 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023;44:4043\u2013140.","journal-title":"Eur Heart J"},{"key":"3055_CR4","first-page":"230","volume":"30","author":"O Bornachea","year":"2018","unstructured":"Bornachea O, Vea A, Llorente-Cortes V. Interplay between epicardial adipose tissue, metabolic and cardiovascular diseases. Clin Investig Arterioscler. 2018;30:230\u20139.","journal-title":"Clin Investig Arterioscler"},{"key":"3055_CR5","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","volume":"7","author":"IJ Neeland","year":"2019","unstructured":"Neeland IJ, Ross R, Despr\u00e9s J-P, Matsuzawa Y, Yamashita S, Shai I, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019;7:715\u201325.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3055_CR6","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41569-022-00679-9","volume":"19","author":"G Iacobellis","year":"2022","unstructured":"Iacobellis G. Epicardial adipose tissue in contemporary cardiology. Nat Rev Cardiol. 2022;19:593\u2013606.","journal-title":"Nat Rev Cardiol"},{"key":"3055_CR7","volume":"9","author":"A Krishnan","year":"2022","unstructured":"Krishnan A, Sharma H, Yuan D, Trollope AF, Chilton L. The role of epicardial adipose tissue in the development of atrial fibrillation, coronary artery disease and chronic heart failure in the context of obesity and type 2 diabetes mellitus: a narrative review. J Cardiovasc Dev Dis. 2022;9:217.","journal-title":"J Cardiovasc Dev Dis"},{"key":"3055_CR8","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.tem.2011.07.003","volume":"22","author":"G Iacobellis","year":"2011","unstructured":"Iacobellis G, Bianco AC. Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features. Trends Endocrinol Metab. 2011;22:450\u20137.","journal-title":"Trends Endocrinol Metab"},{"key":"3055_CR9","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.ahj.2007.03.019","volume":"153","author":"HS Sacks","year":"2007","unstructured":"Sacks HS, Fain JN. Human epicardial adipose tissue: a review. Am Heart J. 2007;153:907\u201317.","journal-title":"Am Heart J"},{"key":"3055_CR10","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.3390\/biom14111465","volume":"14","author":"ML Bodenstab","year":"2024","unstructured":"Bodenstab ML, Varghese RT, Iacobellis G. Cardio-lipotoxicity of epicardial adipose tissue. Biomolecules. 2024;14:1465.","journal-title":"Biomolecules"},{"key":"3055_CR11","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/oby.21059","volume":"23","author":"EA McAninch","year":"2015","unstructured":"McAninch EA, Fonseca TL, Poggioli R, Panos AL, Salerno TA, Deng Y, et al. Epicardial adipose tissue has a unique transcriptome modified in severe coronary artery disease. Obesity. 2015;23:1267\u201378.","journal-title":"Obesity"},{"key":"3055_CR12","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1113\/JP280917","volume":"600","author":"D Santos","year":"2022","unstructured":"Santos D, Carvalho E. Adipose-related microRNAs as modulators of the cardiovascular system: the role of epicardial adipose tissue. J Physiol. 2022;600:1171\u201387.","journal-title":"J Physiol"},{"key":"3055_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00402","volume":"9","author":"J O\u2019Brien","year":"2018","unstructured":"O\u2019Brien J, Hayder H, Zayed Y, Peng C. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne). 2018;9:402.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3055_CR14","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.cmet.2019.07.011","volume":"30","author":"MA Mori","year":"2019","unstructured":"Mori MA, Ludwig RG, Garcia-Martin R, Brand\u00e3o BB, Kahn CR. Extracellular miRNAs: from biomarkers to mediators of physiology and disease. Cell Metab. 2019;30:656\u201373.","journal-title":"Cell Metab"},{"key":"3055_CR15","doi-asserted-by":"publisher","first-page":"e182589","DOI":"10.1172\/jci.insight.182589","volume":"9","author":"BI Burke","year":"2024","unstructured":"Burke BI, Ismaeel A, Long DE, Depa LA, Coburn PT, Goh J, et al. Extracellular vesicle transfer of miR-1 to adipose tissue modifies lipolytic pathways following resistance exercise. JCI Insight. 2024;9:e182589.","journal-title":"JCI Insight"},{"key":"3055_CR16","doi-asserted-by":"publisher","first-page":"12158","DOI":"10.1073\/pnas.1808855115","volume":"115","author":"C Casta\u00f1o","year":"2018","unstructured":"Casta\u00f1o C, Kalko S, Novials A, P\u00e1rrizas M. Obesity-associated exosomal miRNAs modulate glucose and lipid metabolism in mice. Proc Natl Acad Sci U S A. 2018;115:12158\u201363.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3055_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010616","volume":"24","author":"J Szyde\u0142ko","year":"2023","unstructured":"Szyde\u0142ko J, Matyjaszek-Matuszek B. MicroRNAs as biomarkers for coronary artery disease related to type 2 diabetes mellitus\u2014from pathogenesis to potential clinical application. Int J Mol Sci. 2023;24:616.","journal-title":"Int J Mol Sci"},{"key":"3055_CR18","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12933-024-02374-0","volume":"23","author":"J Szyde\u0142ko","year":"2024","unstructured":"Szyde\u0142ko J, Czop M, Petniak A, Lenart-Lipi\u0144ska M, Kocki J, Zapolski T, et al. Identification of plasma miR-4505, miR-4743-5p and miR-4750-3p as novel diagnostic biomarkers for coronary artery disease in patients with type 2 diabetes mellitus: a case-control study. Cardiovasc Diabetol. 2024;23:278.","journal-title":"Cardiovasc Diabetol"},{"key":"3055_CR19","doi-asserted-by":"publisher","DOI":"10.1177\/2042018820928824","volume":"11","author":"RH Christensen","year":"2020","unstructured":"Christensen RH, von Scholten BJ, Lehrskov LL, Rossing P, J\u00f8rgensen PG. Epicardial adipose tissue: an emerging biomarker of cardiovascular complications in type 2 diabetes? Ther Adv Endocrinol Metab. 2020;11:2042018820928824.","journal-title":"Ther Adv Endocrinol Metab"},{"key":"3055_CR20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1471-2261-14-62","volume":"14","author":"F-Z Wu","year":"2014","unstructured":"Wu F-Z, Chou K-J, Huang Y-L, Wu M-T. The relation of location-specific epicardial adipose tissue thickness and obstructive coronary artery disease: systemic review and meta-analysis of observational studies. BMC Cardiovasc Disord. 2014;14:62.","journal-title":"BMC Cardiovasc Disord"},{"key":"3055_CR21","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1093\/ehjci\/jex314","volume":"19","author":"J Mancio","year":"2018","unstructured":"Mancio J, Azevedo D, Saraiva F, Azevedo AI, Pires-Morais G, Leite-Moreira A, et al. Epicardial adipose tissue volume assessed by computed tomography and coronary artery disease: a systematic review and meta-analysis. Eur Heart J Cardiovasc Imaging. 2018;19:490\u20137.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"3055_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12933-019-0807-3","volume":"18","author":"Y Li","year":"2019","unstructured":"Li Y, Liu B, Li Y, Jing X, Deng S, Yan Y, et al. Epicardial fat tissue in patients with diabetes mellitus: a systematic review and meta-analysis. Cardiovasc Diabetol. 2019;18:3.","journal-title":"Cardiovasc Diabetol"},{"key":"3055_CR23","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1530\/JOE-15-0495","volume":"229","author":"E Oc\u0142o\u0144","year":"2016","unstructured":"Oc\u0142o\u0144 E, Latacz A, Zubel\u2013\u0141ojek J, Pierzcha\u0142a\u2013Koziec K. Hyperglycemia-induced changes in miRNA expression patterns in epicardial adipose tissue of piglets. J Endocrinol. 2016;229:259\u201366.","journal-title":"J Endocrinol"},{"key":"3055_CR24","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1093\/cvr\/cvv266","volume":"109","author":"M Vacca","year":"2016","unstructured":"Vacca M, Di Eusanio M, Cariello M, Graziano G, D\u2019Amore S, Petridis FD, et al. Integrative miRNA and whole-genome analyses of epicardial adipose tissue in patients with coronary atherosclerosis. Cardiovasc Res. 2016;109:228\u201339.","journal-title":"Cardiovasc Res"},{"key":"3055_CR25","volume":"2016","author":"Y Liu","year":"2016","unstructured":"Liu Y, Fu W, Lu M, Huai S, Song Y, Wei Y. Role of miRNAs in Epicardial Adipose Tissue in CAD Patients with T2DM. Biomed Res Int. 2016;2016:1629236.","journal-title":"Biomed Res Int"},{"key":"3055_CR26","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.2337\/dc24-S002","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","unstructured":"American Diabetes Association Professional Practice Committee. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes\u20142024. Diabetes Care. 2024;47:S20-42.","journal-title":"Diabetes Care"},{"key":"3055_CR27","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402\u20138.","journal-title":"Methods"},{"key":"3055_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:1-39.e14.","journal-title":"J Am Soc Echocardiogr"},{"key":"3055_CR29","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/oby.2003.45","volume":"11","author":"G Iacobellis","year":"2003","unstructured":"Iacobellis G, Assael F, Ribaudo MC, Zappaterreno A, Alessi G, Di Mario U, et al. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res. 2003;11:304\u201310.","journal-title":"Obes Res"},{"key":"3055_CR30","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.echo.2009.10.013","volume":"22","author":"G Iacobellis","year":"2009","unstructured":"Iacobellis G, Willens HJ. Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr. 2009;22:1311\u20139.","journal-title":"J Am Soc Echocardiogr"},{"key":"3055_CR31","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/oby.2008.6","volume":"16","author":"G Iacobellis","year":"2008","unstructured":"Iacobellis G, Willens HJ, Barbaro G, Sharma AM. Threshold values of high-risk echocardiographic epicardial fat thickness. Obesity. 2008;16:887\u201392.","journal-title":"Obesity"},{"key":"3055_CR32","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","volume":"1","author":"JM Bland","year":"1986","unstructured":"Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307\u201310.","journal-title":"Lancet"},{"key":"3055_CR33","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15:155\u201363.","journal-title":"J Chiropr Med"},{"key":"3055_CR34","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837\u201345.","journal-title":"Biometrics"},{"key":"3055_CR35","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1037\/0022-3514.51.6.1173","volume":"51","author":"RM Baron","year":"1986","unstructured":"Baron RM, Kenny DA. The moderator\u2013mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51:1173\u201382.","journal-title":"J Pers Soc Psychol"},{"key":"3055_CR36","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1037\/a0020761","volume":"15","author":"K Imai","year":"2010","unstructured":"Imai K, Keele L, Tingley D. A general approach to causal mediation analysis. Psychol Methods. 2010;15:309\u201334.","journal-title":"Psychol Methods"},{"key":"3055_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v059.i05","volume":"59","author":"D Tingley","year":"2014","unstructured":"Tingley D, Yamamoto T, Hirose K, Keele L, Imai K. Mediation: R package for causal mediation analysis. J Stat Softw. 2014;59:1\u201338.","journal-title":"J Stat Softw"},{"key":"3055_CR38","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/S0002-9149(99)80116-7","volume":"76","author":"J Shirani","year":"1995","unstructured":"Shirani J, Berezowski K, Roberts WC. Quantitative measurement of normal and excessive (cor adiposum) subepicardial adipose tissue, its clinical significance, and its effect on electrocardiographic QRS voltage. Am J Cardiol. 1995;76:414\u20138.","journal-title":"Am J Cardiol"},{"key":"3055_CR39","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1467-789X.2006.00293.x","volume":"8","author":"SW Rabkin","year":"2007","unstructured":"Rabkin SW. Epicardial fat: properties, function and relationship to obesity. Obes Rev. 2007;8:253\u201361.","journal-title":"Obes Rev"},{"key":"3055_CR40","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.diabres.2014.08.021","volume":"106","author":"DS Mohar","year":"2014","unstructured":"Mohar DS, Salcedo J, Hoang KC, Kumar S, Saremi F, Erande AS, et al. Epicardial adipose tissue volume as a marker of coronary artery disease severity in patients with diabetes independent of coronary artery calcium: findings from the CTRAD study. Diabetes Res Clin Pract. 2014;106:228\u201335.","journal-title":"Diabetes Res Clin Pract"},{"key":"3055_CR41","doi-asserted-by":"publisher","first-page":"204","DOI":"10.5603\/KP.a2016.0167","volume":"75","author":"B Uygur","year":"2017","unstructured":"Uygur B, Celik O, Ozturk D, Erturk M, Otcu H, Ustabas\u0131oglu FE, et al. The relationship between location-specific epicardial adipose tissue volume and coronary atherosclerotic plaque burden in type 2 diabetic patients. Kardiol Pol. 2017;75:204\u201312.","journal-title":"Kardiol Pol"},{"key":"3055_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/clc.70171","volume":"48","author":"AN Akhter","year":"2025","unstructured":"Akhter AN, Aisha F, Moazzam AB, Khan SHB, Malik J, Parveen A. Epicardial fat thickness as a marker of coronary artery disease in diabetics: a single center study. Clin Cardiol. 2025;48:e70171.","journal-title":"Clin Cardiol"},{"key":"3055_CR43","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.numecd.2008.05.002","volume":"19","author":"S Eroglu","year":"2009","unstructured":"Eroglu S, Sade LE, Yildirir A, Bal U, Ozbicer S, Ozgul AS, et al. Epicardial adipose tissue thickness by echocardiography is a marker for the presence and severity of coronary artery disease. Nutr Metab Cardiovasc Dis. 2009;19:211\u20137.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"3055_CR44","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.echo.2015.07.006","volume":"28","author":"Y Hirata","year":"2015","unstructured":"Hirata Y, Yamada H, Kusunose K, Iwase T, Nishio S, Hayashi S, et al. Clinical utility of measuring epicardial adipose tissue thickness with echocardiography using a high-frequency linear probe in patients with coronary artery disease. J Am Soc Echocardiogr. 2015;28:1240-1246.e1.","journal-title":"J Am Soc Echocardiogr"},{"key":"3055_CR45","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.5603\/KP.a2018.0054","volume":"76","author":"R Zehir","year":"2018","unstructured":"Zehir R, G\u00fcner A, Hayiroglu MI, Oz TK, Osken A, Aksu H, et al. Clinical usefulness of epicardial adipose tissue in patients with high-intermediate pre-test probability for coronary artery disease. Kardiol Pol. 2018;76:1002\u20138.","journal-title":"Kardiol Pol"},{"key":"3055_CR46","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ihj.2020.07.014","volume":"72","author":"SK Shambu","year":"2020","unstructured":"Shambu SK, Desai N, Sundaresh N, Babu MS, Madhu B, Gona OJ. Study of correlation between epicardial fat thickness and severity of coronary artery disease. Indian Heart J. 2020;72:445\u20137.","journal-title":"Indian Heart J"},{"key":"3055_CR47","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20190770","volume":"93","author":"CB Monti","year":"2020","unstructured":"Monti CB, Codari M, De Cecco CN, Secchi F, Sardanelli F, Stillman AE. Novel imaging biomarkers: epicardial adipose tissue evaluation. Br J Radiol. 2020;93:20190770.","journal-title":"Br J Radiol"},{"key":"3055_CR48","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12933-017-0650-3","volume":"17","author":"J Kang","year":"2018","unstructured":"Kang J, Kim Y-C, Park JJ, Kim S, Kang S-H, Cho YJ, et al. Increased epicardial adipose tissue thickness is a predictor of new-onset diabetes mellitus in patients with coronary artery disease treated with high-intensity statins. Cardiovasc Diabetol. 2018;17:10.","journal-title":"Cardiovasc Diabetol"},{"key":"3055_CR49","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12933-018-0735-7","volume":"17","author":"D-H Cho","year":"2018","unstructured":"Cho D-H, Joo HJ, Kim M-N, Lim D-S, Shim WJ, Park S-M. Association between epicardial adipose tissue, high-sensitivity C-reactive protein and myocardial dysfunction in middle-aged men with suspected metabolic syndrome. Cardiovasc Diabetol. 2018;17:95.","journal-title":"Cardiovasc Diabetol"},{"key":"3055_CR50","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.3390\/diagnostics12112836","volume":"12","author":"SS Park","year":"2022","unstructured":"Park SS, Jung J, Mintz GS, Jin U, Park J-S, Park B, et al. Epicardial adipose tissue thickness is related to plaque composition in coronary artery disease. Diagnostics. 2022;12:2836.","journal-title":"Diagnostics"},{"key":"3055_CR51","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.numecd.2023.10.016","volume":"34","author":"G Iacobellis","year":"2024","unstructured":"Iacobellis G, Goldberger JJ, Malavazos AE, Munoz Sterling CG, Canturk A. Epicardial fat thickness in type 2 diabetes outpatient care. Nutr Metab Cardiovasc Dis. 2024;34:618\u201323.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"3055_CR52","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.amjcard.2012.04.024","volume":"110","author":"GN Bachar","year":"2012","unstructured":"Bachar GN, Dicker D, Kornowski R, Atar E. Epicardial adipose tissue as a predictor of coronary artery disease in asymptomatic subjects. Am J Cardiol. 2012;110:534\u20138.","journal-title":"Am J Cardiol"},{"key":"3055_CR53","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.ijcard.2017.09.178","volume":"249","author":"J Mancio","year":"2017","unstructured":"Mancio J, Pinheiro M, Ferreira W, Carvalho M, Barros A, Ferreira N, et al. Gender differences in the association of epicardial adipose tissue and coronary artery calcification: EPICHEART study: EAT and coronary calcification by gender. Int J Cardiol. 2017;249:419\u201325.","journal-title":"Int J Cardiol"},{"key":"3055_CR54","doi-asserted-by":"publisher","first-page":"114","DOI":"10.5152\/erp.2023.22123","volume":"27","author":"A Naser","year":"2023","unstructured":"Naser A, Isgandarov K, Sinan G\u00fcven\u00e7 T, Demir I, Kiri\u015f\u00e7i M, \u015eahin M, et al. The relationship between epicardial adipose tissue and visceral adiposity indexes in individuals without established atherosclerotic cardiovascular disease and diabetes mellitus. Endocrinology Res Pract. 2023;27:114\u201320.","journal-title":"Endocrinology Res Pract"},{"key":"3055_CR55","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1089\/met.2013.0107","volume":"12","author":"SW Rabkin","year":"2014","unstructured":"Rabkin SW. The relationship between epicardial fat and indices of obesity and the metabolic syndrome: a systematic review and meta-analysis. Metab Syndr Relat Disord. 2014;12:31\u201342.","journal-title":"Metab Syndr Relat Disord"},{"key":"3055_CR56","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.atherosclerosis.2019.06.915","volume":"288","author":"M Barchuk","year":"2019","unstructured":"Barchuk M, Schreier L, L\u00f3pez G, Cevey A, Baldi J, Fernandez Tom\u00e9 MdelC, et al. Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 and angiopoietin-like protein 4 are associated with the increase of lipoprotein lipase activity in epicardial adipose tissue from diabetic patients. Atherosclerosis. 2019;288:51\u20139.","journal-title":"Atherosclerosis"},{"key":"3055_CR57","doi-asserted-by":"publisher","first-page":"e242","DOI":"10.1161\/ATVBAHA.122.317840","volume":"42","author":"M Barchuk","year":"2022","unstructured":"Barchuk M, Ancel P, Miksztowicz V, Doukbi E, Svilar L, Y\u00f1\u00f3n D, et al. Epicardial adipose tissue ceramides are related to lipoprotein lipase activity in coronary artery disease: unfolding a missing link. Arterioscler Thromb Vasc Biol. 2022;42:e242-51.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3055_CR58","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1016\/j.ijcard.2012.06.008","volume":"167","author":"K Chechi","year":"2013","unstructured":"Chechi K, Blanchard P-G, Mathieu P, Deshaies Y, Richard D. Brown fat like gene expression in the epicardial fat depot correlates with circulating HDL-cholesterol and triglycerides in patients with coronary artery disease. Int J Cardiol. 2013;167:2264\u201370.","journal-title":"Int J Cardiol"},{"key":"3055_CR59","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7150\/ijms.17821","volume":"14","author":"LM P\u00e9rez-Belmonte","year":"2017","unstructured":"P\u00e9rez-Belmonte LM, Moreno-Santos I, Cabrera-Bueno F, S\u00e1nchez-Esp\u00edn G, Castellano D, Such M, et al. Expression of sterol regulatory element-binding proteins in epicardial adipose tissue in patients with coronary artery disease and diabetes mellitus: preliminary study. Int J Med Sci. 2017;14:268\u201374.","journal-title":"Int J Med Sci"},{"key":"3055_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116779","volume":"175","author":"N Puig","year":"2024","unstructured":"Puig N, Rives J, Gil-Millan P, Mi\u00f1ambres I, Ginel A, Tauron M, et al. Apolipoprotein J protects cardiomyocytes from lipid-mediated inflammation and cytotoxicity induced by the epicardial adipose tissue of diabetic patients. Biomed Pharmacother. 2024;175:116779.","journal-title":"Biomed Pharmacother"},{"key":"3055_CR61","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12967-016-0999-1","volume":"14","author":"I Moreno-Santos","year":"2016","unstructured":"Moreno-Santos I, P\u00e9rez-Belmonte LM, Mac\u00edas-Gonz\u00e1lez M, Matar\u00f3 MJ, Castellano D, L\u00f3pez-Garrido M, et al. Type 2 diabetes is associated with decreased PGC1\u03b1 expression in epicardial adipose tissue of patients with coronary artery disease. J Transl Med. 2016;14:243.","journal-title":"J Transl Med"},{"issue":"Suppl 2","key":"3055_CR62","doi-asserted-by":"publisher","first-page":"S371","DOI":"10.2337\/dc11-s250","volume":"34","author":"P Iozzo","year":"2011","unstructured":"Iozzo P. Myocardial, perivascular, and epicardial fat. Diabetes Care. 2011;34(Suppl 2):S371\u20139.","journal-title":"Diabetes Care"},{"key":"3055_CR63","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cca.2013.12.001","volume":"429","author":"\u00d3 P\u00e9rez-M\u00e9ndez","year":"2014","unstructured":"P\u00e9rez-M\u00e9ndez \u00d3, Pacheco HG, Mart\u00ednez-S\u00e1nchez C, Franco M. HDL-cholesterol in coronary artery disease risk: function or structure? Clin Chim Acta. 2014;429:111\u201322.","journal-title":"Clin Chim Acta"},{"key":"3055_CR64","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12933-015-0270-8","volume":"14","author":"MCO Sprandel","year":"2015","unstructured":"Sprandel MCO, Hueb WA, Segre A, Ramires JAF, Kalil-Filho R, Maranh\u00e3o RC. Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus. Cardiovasc Diabetol. 2015;14:107.","journal-title":"Cardiovasc Diabetol"},{"key":"3055_CR65","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nrendo.2015.58","volume":"11","author":"G Iacobellis","year":"2015","unstructured":"Iacobellis G. Local and systemic effects of the multifaceted epicardial adipose tissue depot. Nat Rev Endocrinol. 2015;11:363\u201371.","journal-title":"Nat Rev Endocrinol"},{"key":"3055_CR66","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.numecd.2017.05.010","volume":"27","author":"V Camarena","year":"2017","unstructured":"Camarena V, Sant D, Mohseni M, Salerno T, Zaleski ML, Wang G, et al. Novel atherogenic pathways from the differential transcriptome analysis of diabetic epicardial adipose tissue. Nutr Metab Cardiovasc Dis. 2017;27:739\u201350.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"3055_CR67","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1161\/01.CIR.0000099542.57313.C5","volume":"108","author":"T Mazurek","year":"2003","unstructured":"Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003;108:2460\u20136.","journal-title":"Circulation"},{"key":"3055_CR68","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202100684RR","volume":"35","author":"NN Ballasy","year":"2021","unstructured":"Ballasy NN, Jadli AS, Edalat P, Kang S, Fatehi Hassanabad A, Gomes KP, et al. Potential role of epicardial adipose tissue in coronary artery endothelial cell dysfunction in type 2 diabetes. FASEB J. 2021;35:e21878.","journal-title":"FASEB J"},{"key":"3055_CR69","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12944-021-01451-7","volume":"20","author":"Y-Y Gong","year":"2021","unstructured":"Gong Y-Y, Peng H-Y. Correlation analysis of epicardial adipose tissue thickness, C-reactive protein, interleukin-6, visfatin, juxtaposed with another zinc finger protein 1, and type 2 diabetic macroangiopathy. Lipids Health Dis. 2021;20:25.","journal-title":"Lipids Health Dis"},{"key":"3055_CR70","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.regpep.2010.07.169","volume":"165","author":"I Shibasaki","year":"2010","unstructured":"Shibasaki I, Nishikimi T, Mochizuki Y, Yamada Y, Yoshitatsu M, Inoue Y, et al. Greater expression of inflammatory cytokines, adrenomedullin, and natriuretic peptide receptor-C in epicardial adipose tissue in coronary artery disease. Regul Pept. 2010;165:210\u20137.","journal-title":"Regul Pept"},{"key":"3055_CR71","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12967-019-1842-2","volume":"17","author":"C Santiago-Fern\u00e1ndez","year":"2019","unstructured":"Santiago-Fern\u00e1ndez C, P\u00e9rez-Belmonte LM, Mill\u00e1n-G\u00f3mez M, Moreno-Santos I, Carrasco-Chinchilla F, Ruiz-Salas A, et al. Overexpression of scavenger receptor and infiltration of macrophage in epicardial adipose tissue of patients with ischemic heart disease and diabetes. J Transl Med. 2019;17:95.","journal-title":"J Transl Med"},{"key":"3055_CR72","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1038\/s41598-025-87594-4","volume":"15","author":"G Zhihong","year":"2025","unstructured":"Zhihong G, Yuqiang Z, Linyi J, Yuling Y, Xu Y, Lei X, et al. Correlation analysis between epicardial adipose tissue and acute coronary syndrome. Sci Rep. 2025;15:3015.","journal-title":"Sci Rep"},{"key":"3055_CR73","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1758-5996-6-55","volume":"6","author":"EM Akbas","year":"2014","unstructured":"Akbas EM, Hamur H, Demirtas L, Bakirci EM, Ozcicek A, Ozcicek F, et al. Predictors of epicardial adipose tissue in patients with type 2 diabetes mellitus. Diabetol Metab Syndr. 2014;6:55.","journal-title":"Diabetol Metab Syndr"},{"key":"3055_CR74","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.atherosclerosis.2019.01.033","volume":"284","author":"Z Liu","year":"2019","unstructured":"Liu Z, Wang S, Wang Y, Zhou N, Shu J, Stamm C, et al. Association of epicardial adipose tissue attenuation with coronary atherosclerosis in patients with a high risk of coronary artery disease. Atherosclerosis. 2019;284:230\u20136.","journal-title":"Atherosclerosis"},{"key":"3055_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8060780","volume":"8","author":"D de Gonzalo-Calvo","year":"2019","unstructured":"de Gonzalo-Calvo D, Vilades D, Mart\u00ednez-Camblor P, Vea \u00c0, Ferrero-Gregori A, Nasarre L, et al. Plasma microRNA profiling reveals novel biomarkers of epicardial adipose tissue: a multidetector computed tomography study. J Clin Med. 2019;8:780.","journal-title":"J Clin Med"},{"key":"3055_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14030862","volume":"14","author":"J Rives","year":"2025","unstructured":"Rives J, Gil-Millan P, Vilad\u00e9s D, Garc\u00eda-Osuna \u00c1, Genua I, Mi\u00f1ambres I, et al. Low-density lipoprotein subfraction phenotype is associated with epicardial adipose tissue volume in type 2 diabetes. J Clin Med. 2025;14:862.","journal-title":"J Clin Med"},{"key":"3055_CR77","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ijcard.2020.09.045","volume":"324","author":"W Huang","year":"2021","unstructured":"Huang W, Wu X, Xue Y, Zhou Y, Xiang H, Yang W, et al. MicroRNA-3614 regulates inflammatory response via targeting TRAF6-mediated MAPKs and NF-\u03baB signaling in the epicardial adipose tissue with coronary artery disease. Int J Cardiol. 2021;324:152\u201364.","journal-title":"Int J Cardiol"},{"key":"3055_CR78","doi-asserted-by":"publisher","first-page":"5297","DOI":"10.3390\/ijms23105297","volume":"23","author":"B Flinn","year":"2022","unstructured":"Flinn B, Adams C, Chowdhury N, Gress T, Santanam N. Profiling of non-coding regulators and their targets in epicardial fat from patients with coronary artery disease. Int J Mol Sci. 2022;23:5297.","journal-title":"Int J Mol Sci"},{"key":"3055_CR79","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1536\/ihj.22-163","volume":"63","author":"J-G Wu","year":"2022","unstructured":"Wu J-G, Yang W-K, Huang H-Z, Tang K, Zheng G-D. MiRNA-6870-3p regulates lipopolysaccharide induced epicardial adipose tissue inflammatory genes via targeting Tollip-mediated JNK and NF-\u03baB signaling in coronary artery disease. Int Heart J. 2022;63:915\u201327.","journal-title":"Int Heart J"},{"key":"3055_CR80","doi-asserted-by":"publisher","first-page":"206","DOI":"10.31083\/j.rcm2306206","volume":"23","author":"J Liu","year":"2022","unstructured":"Liu J, Gao A, Liu Y, Sun Y, Zhang D, Lin X, et al. MicroRNA expression profiles of epicardial adipose tissue-derived exosomes in patients with coronary atherosclerosis. Rev Cardiovasc Med. 2022;23:206.","journal-title":"Rev Cardiovasc Med"},{"key":"3055_CR81","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1016\/j.bbrc.2017.11.195","volume":"495","author":"C Li","year":"2018","unstructured":"Li C, Li S, Zhang F, Wu M, Liang H, Song J, et al. Endothelial microparticles-mediated transfer of microRNA-19b promotes atherosclerosis via activating perivascular adipose tissue inflammation in apoE\u2212\/\u2212 mice. Biochem Biophys Res Commun. 2018;495:1922\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"3055_CR82","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1111\/bph.15972","volume":"180","author":"P Ranasinghe","year":"2023","unstructured":"Ranasinghe P, Addison ML, Dear JW, Webb DJ. Small interfering RNA: discovery, pharmacology and clinical development-an introductory review. Br J Pharmacol. 2023;180:2697\u2013720.","journal-title":"Br J Pharmacol"},{"key":"3055_CR83","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/bph.17302","volume":"182","author":"Z Bereczki","year":"2025","unstructured":"Bereczki Z, Benczik B, Balogh OM, Marton S, Puhl E, P\u00e9terv\u00e1ri M, et al. Mitigating off-target effects of small RNAs: conventional approaches, network theory and artificial intelligence. Br J Pharmacol. 2025;182:340\u201379.","journal-title":"Br J Pharmacol"},{"key":"3055_CR84","doi-asserted-by":"publisher","first-page":"450","DOI":"10.5543\/tkda.2014.72772","volume":"42","author":"A \u00c7elik","year":"2014","unstructured":"\u00c7elik A, Topuz M, G\u00f6z\u00fckara Y, G\u00fcnde\u015f A, Ye\u015fil E, Ovla D, et al. The relationship between epicardial adipose tissue and endothelial dysfunction in patients with type 2 diabetes mellitus. Turk Kardiyol Dern Ars. 2014;42:450\u20135.","journal-title":"Turk Kardiyol Dern Ars"},{"key":"3055_CR85","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.amjcard.2014.05.057","volume":"114","author":"EM Groves","year":"2014","unstructured":"Groves EM, Erande AS, Le C, Salcedo J, Hoang KC, Kumar S, et al. Comparison of epicardial adipose tissue volume and coronary artery disease severity in asymptomatic adults with versus without diabetes mellitus. Am J Cardiol. 2014;114:686\u201391.","journal-title":"Am J Cardiol"},{"key":"3055_CR86","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1111\/j.1365-2265.2008.03411.x","volume":"70","author":"C-P Wang","year":"2009","unstructured":"Wang C-P, Hsu H-L, Hung W-C, Yu T-H, Chen Y-H, Chiu C-A, et al. Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis. Clin Endocrinol Oxf. 2009;70:876\u201382.","journal-title":"Clin Endocrinol Oxf"},{"key":"3055_CR87","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3945\/ajcn.2008.27358","volume":"90","author":"J Ding","year":"2009","unstructured":"Ding J, Hsu F-C, Harris TB, Liu Y, Kritchevsky SB, Szklo M, et al. The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr. 2009;90:499\u2013504.","journal-title":"Am J Clin Nutr"},{"key":"3055_CR88","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/oby.20090","volume":"21","author":"J McClain","year":"2013","unstructured":"McClain J, Hsu F-C, Brown E, Burke G, Carr J, Harris T, et al. Pericardial adipose tissue and coronary artery calcification in the Multi-Ethnic Study of Atherosclerosis (MESA). Obesity. 2013;21:1056\u201363.","journal-title":"Obesity"},{"key":"3055_CR89","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1139\/cjpp-2024-0188","volume":"102","author":"L Braescu","year":"2024","unstructured":"Braescu L, Sturza A, Sosdean R, Aburel OM, Lazar MA, Muntean D, et al. Echocardiographic assessment of epicardial adipose tissue thickness as independent predictor in coronary artery disease. Can J Physiol Pharmacol. 2024;102:648\u201360.","journal-title":"Can J Physiol Pharmacol"},{"key":"3055_CR90","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1177\/1479164119827602","volume":"16","author":"S Yafei","year":"2019","unstructured":"Yafei S, Elsewy F, Youssef E, Ayman M, Elshafei M, Abayazeed R. Echocardiographic association of epicardial fat with carotid intima\u2013media thickness in patients with type 2 diabetes. Diabetes Vasc Dis Res. 2019;16:378\u201384.","journal-title":"Diabetes Vasc Dis Res"},{"key":"3055_CR91","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12933-019-0917-y","volume":"18","author":"RH Christensen","year":"2019","unstructured":"Christensen RH, von Scholten BJ, Hansen CS, Jensen MT, Vilsb\u00f8ll T, Rossing P, et al. Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2 diabetes. Cardiovasc Diabetol. 2019;18:114.","journal-title":"Cardiovasc Diabetol"},{"key":"3055_CR92","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00592-020-01608-3","volume":"58","author":"T Xu","year":"2021","unstructured":"Xu T, Chen S, Yang F, Wang Y, Zhang K, Fu G, et al. The impact of homocysteine on the risk of coronary artery diseases in individuals with diabetes: a Mendelian randomization study. Acta Diabetol. 2021;58:301\u20137.","journal-title":"Acta Diabetol"},{"key":"3055_CR93","doi-asserted-by":"publisher","first-page":"5163","DOI":"10.1210\/jc.2003-030698","volume":"88","author":"G Iacobellis","year":"2003","unstructured":"Iacobellis G, Ribaudo MC, Assael F, Vecci E, Tiberti C, Zappaterreno A, et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab. 2003;88:5163\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"3055_CR94","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.amjcard.2010.01.368","volume":"105","author":"AE Malavazos","year":"2010","unstructured":"Malavazos AE, Di Leo G, Secchi F, Lupo EN, Dogliotti G, Coman C, et al. Relation of echocardiographic epicardial fat thickness and myocardial fat. Am J Cardiol. 2010;105:1831\u20135.","journal-title":"Am J Cardiol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-03055-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-03055-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-03055-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T13:03:18Z","timestamp":1770728598000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-025-03055-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":94,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3055"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-03055-2","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]},"assertion":[{"value":"1 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Bioethics Committee of the Medical University of Lublin, Poland (protocol code KE-0254\/198\/2020). Written informed consent was obtained from all participants involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}